CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,470,580 | -66.9% | 3,389,215 | -50.0% | 0.07% | -33.3% |
| Q4 2022 | $4,448,006 | +52.6% | 6,778,430 | +100.0% | 0.10% | -25.0% |
| Q3 2022 | $2,915,000 | +56.7% | 3,389,215 | 0.0% | 0.13% | +57.1% |
| Q2 2022 | $1,860,000 | -50.6% | 3,389,215 | 0.0% | 0.08% | -35.4% |
| Q1 2022 | $3,762,000 | -35.5% | 3,389,215 | 0.0% | 0.13% | -43.2% |
| Q4 2021 | $5,829,000 | -44.0% | 3,389,215 | 0.0% | 0.23% | -52.0% |
| Q3 2021 | $10,405,000 | -21.3% | 3,389,215 | 0.0% | 0.48% | -32.8% |
| Q2 2021 | $13,218,000 | +95.2% | 3,389,215 | +39.6% | 0.71% | +41.2% |
| Q1 2021 | $6,773,000 | -8.8% | 2,427,677 | 0.0% | 0.50% | -23.2% |
| Q4 2020 | $7,429,000 | -49.7% | 2,427,677 | 0.0% | 0.66% | -45.7% |
| Q3 2020 | $14,760,000 | +2.9% | 2,427,677 | 0.0% | 1.21% | -39.6% |
| Q2 2020 | $14,348,000 | +123.0% | 2,427,677 | 0.0% | 2.00% | +135.0% |
| Q1 2020 | $6,433,000 | +59.0% | 2,427,677 | +63.2% | 0.85% | +2.0% |
| Q4 2019 | $4,047,000 | -77.6% | 1,487,874 | 0.0% | 0.83% | -69.1% |
| Q3 2019 | $18,033,000 | +5.9% | 1,487,874 | 0.0% | 2.70% | -0.3% |
| Q2 2019 | $17,036,000 | – | 1,487,874 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 552 | $2 | 0.00% |